Literature DB >> 15622001

Extended hepatectomy for intrahepatic cholangiocellular carcinoma (ICC): when is it worthwhile? Single center experience with 27 resections in 50 patients over a 5-year period.

Hauke Lang1, Georgios C Sotiropoulos, Nils R Frühauf, Marco Dömland, Andreas Paul, Eva-Maria Kind, Massimo Malagó, Christoph E Broelsch.   

Abstract

OBJECTIVE: To evaluate the role of extended hepatectomy in locally advanced intrahepatic cholangiocarcinoma (ICC). SUMMARY BACKGROUND DATA: ICC is a rare tumor which has to be clearly distinguished from hepatocellular carcinoma and extrahepatic bile duct carcinoma. It is believed that long-term survival can only be achieved by surgical resection.
METHODS: Between April 1998 and March 2003, 50 patients with locally advanced ICC (tumor involvement of more than 4 liver segments) underwent surgical exploration. Data were analyzed with regard to patients' characteristics, intraoperative details, pathologic findings, and outcome measured by tumor recurrence, treatment of recurrence, and survival.
RESULTS: Resectability rate was 27 of 50 (54%). There were 19 extended right and 8 extended left hepatectomies. In addition, in 16 patients the following 29 procedures were performed: resection of hilar bifurcation (n = 12), partial resection of diaphragm (n = 6), partial resection of vena cava (n = 4), resection and reinsertion of left liver vein (n = 1), portal vein resection (n = 5), resection and reconstruction of right hepatic artery (n = 1). Complete tumor removal (R0-resection) was achieved in 16 patients. In 11 cases, there was microscopic tumor at the cutting margin (R1-resection). Following resection, the overall 1- and 3-year-survival rates were 69% and 55%. After R1-resection and explorative laparotomy, median survival was 5 and 7 months, respectively. Following R0-resection, the calculated median survival and 1- and 3-year-survival rates are 46 months, 94% and 82% (P = 0.0039; log-rank test). Tumor recurred in 6 of 16 patients, and so far 2 patients died of recurrence 28 and 46 months after operation.
CONCLUSIONS: R0-resection can provide prolonged survival, even in patients with advanced ICC. In particular in solitary tumors without vascular invasion (UICC stage I, sixth classification) there is a major chance for long-term survival and cure. The poor results after R1-resection and the high operative morbidity do not justify palliative resections but underline the need for an improved preoperative assessment of resectability, as well as an aggressive intraoperative approach, to achieve complete tumor resection.

Entities:  

Mesh:

Year:  2005        PMID: 15622001      PMCID: PMC1356856          DOI: 10.1097/01.sla.0000149426.08580.a1

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  33 in total

1.  Extended resection for intrahepatic cholangiocarcinoma in Japan.

Authors:  M Yamamoto; K Takasaki; T Yoshikawa
Journal:  J Hepatobiliary Pancreat Surg       Date:  1999

2.  Pulse-inversion mode imaging of liver specific microbubbles: improved detection of subcentimetre metastases.

Authors:  C J Harvey; M J Blomley; R J Eckersley; R A Heckemann; J Butler-Barnes; D O Cosgrove
Journal:  Lancet       Date:  2000-03-04       Impact factor: 79.321

3.  Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States.

Authors:  T Patel
Journal:  Hepatology       Date:  2001-06       Impact factor: 17.425

4.  Liver transplantation for cholangiocarcinoma: results in 207 patients.

Authors:  C G Meyer; I Penn; L James
Journal:  Transplantation       Date:  2000-04-27       Impact factor: 4.939

Review 5.  Liver transplantation for cholangiocellular carcinoma: analysis of a single-center experience and review of the literature.

Authors:  M Shimoda; D G Farmer; S D Colquhoun; M Rosove; R M Ghobrial; H Yersiz; P Chen; R W Busuttil
Journal:  Liver Transpl       Date:  2001-12       Impact factor: 5.799

6.  Value of lymph node dissection during resection of intrahepatic cholangiocarcinoma.

Authors:  M Shimada; Y Yamashita; S Aishima; K Shirabe; K Takenaka; K Sugimachi
Journal:  Br J Surg       Date:  2001-11       Impact factor: 6.939

7.  Retrospective analysis of prognostic factors after liver resection and transplantation for cholangiocellular carcinoma.

Authors:  A Weimann; H Varnholt; H J Schlitt; H Lang; P Flemming; C Hustedt; G Tusch; R Raab
Journal:  Br J Surg       Date:  2000-09       Impact factor: 6.939

8.  Long-term survival and prognostic factors in the surgical treatment of mass-forming type cholangiocarcinoma.

Authors:  K Inoue; M Makuuchi; T Takayama; G Torzilli; J Yamamoto; K Shimada; T Kosuge; S Yamasaki; M Konishi; T Kinoshita; S Miyagawa; S Kawasaki
Journal:  Surgery       Date:  2000-05       Impact factor: 3.982

9.  Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes.

Authors:  S M Weber; W R Jarnagin; D Klimstra; R P DeMatteo; Y Fong; L H Blumgart
Journal:  J Am Coll Surg       Date:  2001-10       Impact factor: 6.113

10.  Aggressive surgical treatment of intrahepatic cholangiocarcinoma: predictors of outcomes.

Authors:  S Roayaie; J V Guarrera; M Q Ye; S N Thung; S Emre; T M Fishbein; S R Guy; P A Sheiner; C M Miller; M E Schwartz
Journal:  J Am Coll Surg       Date:  1998-10       Impact factor: 6.113

View more
  54 in total

1.  Outcomes following resection of intrahepatic cholangiocarcinoma.

Authors:  Parissa Tabrizian; Ghalib Jibara; Jaclyn F Hechtman; Bernardo Franssen; Daniel M Labow; Myron E Schwartz; Swan N Thung; Umut Sarpel
Journal:  HPB (Oxford)       Date:  2014-11-14       Impact factor: 3.647

2.  Primary liver cancer: intrahepatic cholangiocarcinoma emerges from the shadows.

Authors:  Susan Tsai; Hari Nathan; Timothy M Pawlik
Journal:  Updates Surg       Date:  2010-08

3.  A comparative evaluation of ablations produced by high-frequency coagulation-, argon plasma coagulation-, and cryotherapy devices in porcine liver.

Authors:  J Sperling; C Ziemann; J Schuld; M W Laschke; M K Schilling; M D Menger; O Kollmar
Journal:  Int J Colorectal Dis       Date:  2012-05-31       Impact factor: 2.571

4.  Implications of CA19-9 elevation for survival, staging, and treatment sequencing in intrahepatic cholangiocarcinoma: A national cohort analysis.

Authors:  John R Bergquist; Tommy Ivanics; Curtis B Storlie; Ryan T Groeschl; May C Tee; Elizabeth B Habermann; Rory L Smoot; Michael L Kendrick; Michael B Farnell; Lewis R Roberts; Gregory J Gores; David M Nagorney; Mark J Truty
Journal:  J Surg Oncol       Date:  2016-07-20       Impact factor: 3.454

5.  Intrahepatic recurrence after surgery in patients with intrahepatic cholangiocarcinoma.

Authors:  Masakazu Yamamoto; Shun-ichi Ariizumi
Journal:  J Gastroenterol       Date:  2006-09       Impact factor: 7.527

6.  Survival outcomes and prognostic factors of surgical therapy for all potentially resectable intrahepatic cholangiocarcinoma: a large single-center cohort study.

Authors:  Xianwu Luo; Lei Yuan; Yi Wang; Ruiliang Ge; Yanfu Sun; Gongtian Wei
Journal:  J Gastrointest Surg       Date:  2014-01-07       Impact factor: 3.452

7.  Clinicopathological and prognostic analysis of 429 patients with intrahepatic cholangiocarcinoma.

Authors:  Wei-Feng Shen; Wei Zhong; Feng Xu; Tong Kan; Li Geng; Feng Xie; Cheng-Jun Sui; Jia-Mei Yang
Journal:  World J Gastroenterol       Date:  2009-12-21       Impact factor: 5.742

8.  Patterns and prognostic significance of lymph node dissection for surgical treatment of perihilar and intrahepatic cholangiocarcinoma.

Authors:  Alfredo Guglielmi; Andrea Ruzzenente; Tommaso Campagnaro; Alessandro Valdegamberi; Fabio Bagante; Francesca Bertuzzo; Simone Conci; Calogero Iacono
Journal:  J Gastrointest Surg       Date:  2013-09-19       Impact factor: 3.452

9.  Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.

Authors:  Alfredo Guglielmi; Andrea Ruzzenente; Tommaso Campagnaro; Silvia Pachera; Alessandro Valdegamberi; Paola Nicoli; Alessandro Cappellani; Giulio Malfermoni; Calogero Iacono
Journal:  World J Surg       Date:  2009-06       Impact factor: 3.352

10.  Liver metastasis with intraductal invasion originating from rectal cancer: report of a case.

Authors:  Hiroto Kayashima; Akinobu Taketomi; Yo-ichi Yamashita; Yousuke Kuroda; Dai Kitagawa; Norifumi Harimoto; Eiji Tsujita; Yoshihiko Maehara
Journal:  Surg Today       Date:  2008-07-31       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.